AU2003250128A1 - Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) - Google Patents
Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37)Info
- Publication number
- AU2003250128A1 AU2003250128A1 AU2003250128A AU2003250128A AU2003250128A1 AU 2003250128 A1 AU2003250128 A1 AU 2003250128A1 AU 2003250128 A AU2003250128 A AU 2003250128A AU 2003250128 A AU2003250128 A AU 2003250128A AU 2003250128 A1 AU2003250128 A1 AU 2003250128A1
- Authority
- AU
- Australia
- Prior art keywords
- gpr37
- therapeutics
- diagnostics
- diseases associated
- coupled receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Endocrinology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02016940 | 2002-08-01 | ||
EP02016940.5 | 2002-08-01 | ||
PCT/EP2003/007956 WO2004013637A1 (en) | 2002-08-01 | 2003-07-22 | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003250128A1 true AU2003250128A1 (en) | 2004-02-23 |
Family
ID=31197782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003250128A Abandoned AU2003250128A1 (en) | 2002-08-01 | 2003-07-22 | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003250128A1 (en) |
WO (1) | WO2004013637A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005103681A1 (en) * | 2004-04-24 | 2005-11-03 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with endothelin receptor type b-like protein 1(etbr-lp-1) |
US20190216891A1 (en) * | 2016-03-06 | 2019-07-18 | Yeda Research And Development Co., Ltd. | Method for modulating myelination |
EP3814372A4 (en) * | 2018-06-04 | 2022-03-23 | Duke University | Compositions and methods for treating pain, inflammation, infection, malaria, and sepsis |
CN117802214A (en) * | 2022-09-30 | 2024-04-02 | 厦门英博迈生物科技有限公司 | Marker for diagnosis of multiple sclerosis and application thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750370A (en) * | 1995-06-06 | 1998-05-12 | Human Genome Sciences, Inc. | Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor |
CN1284536C (en) * | 2000-09-18 | 2006-11-15 | 威克斯医药有限公司 | Antalgic method by general medicine application |
WO2002061087A2 (en) * | 2000-12-19 | 2002-08-08 | Lifespan Biosciences, Inc. | Antigenic peptides, such as for g protein-coupled receptors (gpcrs), antibodies thereto, and systems for identifying such antigenic peptides |
WO2002068600A2 (en) * | 2001-02-26 | 2002-09-06 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human g protein-coupled receptors |
CN1547617A (en) * | 2001-06-25 | 2004-11-17 | 2 | Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
JP2003018992A (en) * | 2001-06-28 | 2003-01-21 | Inst Of Physical & Chemical Res | Pael receptor, pael receptor expression cell and animal, amd method for screening drug for parkinson disease |
-
2003
- 2003-07-22 WO PCT/EP2003/007956 patent/WO2004013637A1/en not_active Application Discontinuation
- 2003-07-22 AU AU2003250128A patent/AU2003250128A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004013637A1 (en) | 2004-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003251471A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 5(cxcr5) | |
AU2003214249A1 (en) | Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1) | |
AU2003214072A1 (en) | Diagnostics and therapeutics for diseases associated with the n-formyl peptide receptor 1 (fpr 1) | |
AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
AU2003240589A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 4 (gpr4) | |
AU2003229767A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
AU2003240720A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5) | |
AU2003273994A1 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
AU2003276106A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) | |
AU2003250165A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 19 (gpr19) | |
AU2003301892A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 3 (gpr3) | |
AU2003246726A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 45 (gpr45) | |
AU2003274005A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 6 (gpr6) | |
AU2003206749A1 (en) | Diagnostics and therapeutics for diseases associated with the gpr65 receptor | |
AU2003240721A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4) | |
AU2003283266A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) | |
AU2003221502A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) | |
AU2003267443A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
AU2003229753A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
AU2003266238A1 (en) | Diagnostics and therapeutics for diseases associated with ovarian cancer g-protein coupled receptor 1 (ogr-1) | |
AU2003218638A1 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
AU2003279308A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 73a (gpr73a) | |
AU2003276097A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) | |
AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
AU2003219030A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled orphan receptor 21 (gpr21) |